You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Mifamurtide for the treatment of osteosarcoma

  • Technology appraisal guidance
  • Reference number: TA235
  • Published:  26 October 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive Appendix A: decision paper presented to the Institute's Guidance Executive
27 January 2014
(104.31 Kb 30 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 23 January 2014

Back to top